about
Recombinant prion protein induces a new transmissible prion disease in wild-type animals.Emerging infectious diseases: vulnerabilities, contributing factors and approachesTransmissibility of H-Type Bovine Spongiform Encephalopathy to Hamster PrP Transgenic Mice.Detection of sub-clinical CWD infection in conventional test-negative deer long after oral exposure to urine and feces from CWD+ deer.Characterization of the genomic region containing the Shadow of Prion Protein (SPRN) gene in sheep.Conversion efficiency of bank vole prion protein in vitro is determined by residues 155 and 170, but does not correlate with the high susceptibility of bank voles to sheep scrapie in vivo.Evaluation of the possible transmission of BSE and scrapie to gilthead sea bream (Sparus aurata)Transmission barriers for bovine, ovine, and human prions in transgenic mice.Human prion strain selection in transgenic mice.Prions in the urine of patients with variant Creutzfeldt-Jakob disease.Transmission of elk and deer prions to transgenic miceHistorical perspectives in gonadotrophin therapy.Mechanistic insights into the cure of prion disease by novel antiprion compoundsPrion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type.Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK?In utero transmission and tissue distribution of chronic wasting disease-associated prions in free-ranging Rocky Mountain elkPrion diseases: from protein to cell pathology.Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease.Transmission of atypical scrapie to homozygous ARQ sheep.Small RNA drugs for prion disease: a new frontier.Prions: generation and spread versus neurotoxicity.Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal InvasionUnique structural properties associated with mouse prion Δ105-125 protein.Cytosolic prion protein toxicity is independent of cellular prion protein expression and prion propagation.Projections of the future course of the primary vCJD epidemic in the UK: inclusion of subclinical infection and the possibility of wider genetic susceptibility.Optimal tracking and testing of U.S. and Canadian herds for BSE: a value-of-information (VOI) approach.Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease.High incidence of scrapie induced by repeated injections of subinfectious prion doses.What Is Our Current Understanding of PrPSc-Associated Neurotoxicity and Its Molecular Underpinnings?Prion inactivation and medical instrument reprocessing: challenges facing healthcare facilities.
P2860
Q24645106-27808A99-341C-416F-BF20-701881F33DDCQ28287659-A01396EA-281C-4437-A7C3-A77983BA06F5Q28550238-7510AC0A-609D-40D6-B9FA-5A2C0DB08F7AQ30946000-DE853D19-FB10-4A14-BC6D-DAB67B92B004Q33286202-8A9CCF97-0AB1-49D7-B022-1122C8ADD4B3Q33449340-B8A38286-08D2-46D0-A421-3A359C4C0F31Q33487702-174402A0-3DD8-4C3E-9816-483D6493BE74Q33754930-566B7F55-0726-48B8-B54A-892DFC56F024Q34112488-7BE6FDB3-3727-4431-8F70-EBAB79B080AEQ34173236-AECD1814-10D1-46B3-B7A3-C3BC9AE7CE6DQ35024303-E0EDE570-A8FD-415D-9E72-BD408BC5D0A5Q35896964-7741300C-00A8-4CEE-872C-6118C044ACACQ36099134-CA045FD5-7D65-4641-9776-9BB80BDA1EAAQ36607110-8F0D3E44-A7A4-4427-8336-71CCF78D78B8Q36638892-0FF3BA45-9CF2-42A3-A558-333AB9496442Q36725560-E10FED79-EC34-4551-8707-89B5122C82FEQ37075786-69C4BD18-5D08-4850-B65D-BE08176B3B22Q37328569-17B6DDEF-E288-4ABD-A9C1-1DB47119C22BQ37393844-C5F8F814-1593-447B-88C9-1984A239371DQ38121120-B3AD4EF2-83D6-473A-AF03-2943FB511580Q38214581-04842249-60F5-4E92-9F2D-824B70E09C6CQ38826332-3DD11F35-0616-4093-AD9F-82A30DCA9C1AQ39139955-D0DA19F0-C10D-43B7-8068-C1222CEF7DC7Q40191573-38F0ADCA-8E7C-406E-B6D0-80D77FA33F17Q40306174-1F2E6DB2-FE57-4245-A62E-6BD99D107BEAQ40375118-03A67763-2D2B-425E-8632-ABB731189EE0Q40399825-4E174906-8C47-408B-BAC2-F22137D2648AQ41990883-F571CCAB-3636-425D-9A91-1F13C37D7C95Q47342598-7534E197-C762-4D31-8BBA-13463F0F88C1Q47701165-9C321FCC-826E-4A9C-A5AE-0EDB8A7087E9
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Subclinical prion infection in humans and animals.
@ast
Subclinical prion infection in humans and animals.
@en
type
label
Subclinical prion infection in humans and animals.
@ast
Subclinical prion infection in humans and animals.
@en
prefLabel
Subclinical prion infection in humans and animals.
@ast
Subclinical prion infection in humans and animals.
@en
P356
P1476
Subclinical prion infection in humans and animals.
@en
P2093
Andrew F Hill
John Collinge
P304
P356
10.1093/BMB/66.1.161
P577
2003-01-01T00:00:00Z